regarding recurrence

Options
kiran2106
kiran2106 Member Posts: 3
edited June 2014 in HER2+ (Positive) Breast Cancer

idc with pt2n0m0 grade 3 er/pr- her/neu+ on AC chemo followed by 4 cycles of docetaxel+trastuzumab

what is the chance of local and distant recurrence in future

· Share on FacebookShare on Twitter

Comments

  • septembersong
    septembersong Member Posts: 287
    edited March 2014

    Kiran2106,

    That's really a question for your oncologist. Many factors are involved in estimating chances of local or distant recurrence, and even with the best medical information, there's some uncertainty. Treatments for her2/neu+ BC are improving all the time. Your best bet is to find a medical team you trust and that answers your questions, take good care of yourself physically and mentally, and stay focused on the present. Good luck. 

    Ann

    · Share on FacebookShare on Twitter
  • ben50
    ben50 Member Posts: 46
    edited March 2014

    You can also plug in your diagnosis/information in this Breast Cancer Survival Calculator to get a rudamentary idea: http://www.predict.nhs.uk/predict.shtml. 

    · Share on FacebookShare on Twitter
  • mjm1
    mjm1 Member Posts: 139
    edited April 2014

    If you / future readers are interested in some of the clinical trial results (which include recurrence and survival rates), here's a few links:

    http://www.kreftportalen.no/fmfiles/re7237004/Herc...

    https://www.bcirg.org/NR/rdonlyres/eno7mvfpseiqi5g...

    Not sure if yours is the same AC-TH regime, but in the BCIRG-006 study, 93% of the node negative her2+ group on this regime were disease free at 5 years. The 7% included both local and distant recurrences. The AC regime is a bit tougher on the heart, so some oncs prefer TCH, and they tend to weigh up the advantages and disadvantages for each patient.


    · Share on FacebookShare on Twitter

Categories